Profile
Meryle J.
Melnicoff is currently the Director at Friendship Bridge and the Director-Business Development at The Wistar Institute.
Previously, she worked as an Advisor at Ben Franklin Technology Partners.
Melnicoff received graduate and doctorate degrees from the University of Pennsylvania.
Meryle J. Melnicoff active positions
| Companies | Position | Start |
|---|---|---|
The Wistar Institute
The Wistar Institute BiotechnologyHealth Technology Provides biomedical research services | Corporate Officer/Principal | - |
Friendship Bridge
Friendship Bridge Services to the Health IndustryHealth Services Operates charitable organization that creates opportunities to empower women | Director/Board Member | - |
Former positions of Meryle J. Melnicoff
| Companies | Position | End |
|---|---|---|
Ben Franklin Technology Partners /Ventures/
Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Tech Partners invests in companies located in the US. The firm focuses on IT, life sciences and physical sciences. It participates in seed and early-stage capital requirements. | Investment Committee Member | - |
Training of Meryle J. Melnicoff
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Friendship Bridge
Friendship Bridge Services to the Health IndustryHealth Services Operates charitable organization that creates opportunities to empower women | Health Services |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wistar Institute
The Wistar Institute BiotechnologyHealth Technology Provides biomedical research services | Health Technology |
Ben Franklin Technology Partners /Ventures/
Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Tech Partners invests in companies located in the US. The firm focuses on IT, life sciences and physical sciences. It participates in seed and early-stage capital requirements. | Finance |
- Stock Market
- Insiders
- Meryle J. Melnicoff
















